Ignorer les liens de navigation
Qui sommes nous ? Référence-Recherche Pôle Formation Formation universitaire Formation continue E-Formation Formation en partenariat DPC Documentation & publications Service QRE Sang & Transfusion sanguine Europe & International
INTS in English INTS in English
 
 


Votre recherche : [La BTT] AUTEUR égal van der Schoot CE
39 résultat(s)


    page 1/2    
 
BTT Daniels G, van der Schoot CE, Olsson ML. Report of the fourth International Workshop on molecular blood group genotyping. Vox Sang. 2011;101:327-332.
Thèmes : Systèmes de groupes sanguins ; maj-2012-02
Notice PubMed
BTT Scheffer PG, van der Schoot CE, Page-Christiaens GC, de Haas M. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. BJOG. 2011;118:1340-1348.
Thèmes : Méthodes en immuno-hématologie ; maj-2012-09
Notice PubMed
BTT Scheffer PG, de Haas M, van der Schoot CE. The controversy about controls for fetal blood group genotyping by cell-free fetal DNA in maternal plasma. Curr Opin Hematol. 2011;18:467-473.
Thèmes : Méthodes en immuno-hématologie ; maj-2012-09
Notice PubMed
BTT Veldhuisen B, Ligthart PC, Vidarsson G, Roels I, Folman CC, van der Schoot CE, de Haas M. Molecular analysis of the York antigen of the Knops blood group system. Transfusion. 2011;51:1389-1396.
Thèmes : Systèmes de groupes sanguins ; maj-2012-02
Notice PubMed
BTT Daniels G, van der Schoot CE, Gassner C, Olsson ML. Report of the third international workshop on molecular blood group genotyping. Vox Sang. 2009;96:337-343.
Thèmes : Systèmes de groupes sanguins ; Méthodes en immuno-hématologie ; maj-2009-10
BTT van der Schoot CE, de Haas M, Engelfriet CP, Reesink HW, Panzer S, Jungbauer C, Schwartz DM, Mayr WR, Castilho L, St-Louis M, Long A, Denomme G, Semple E, Fernandes B, Flegel WA, Wagner F, Doescher A, Poli F, Villa MA, Paccapelo C, Veldhuisen B, Nogues N, Muniz-Diaz E, Daniels G, Martin P, Finning K, Reid ME. Genotyping for red blood cell polymorphisms. Vox Sang. 2009;96:167-179.
Thèmes : Systèmes de groupes sanguins ; Méthodes en immuno-hématologie ; maj-2009-04
BTT Veldhuisen B, van der Schoot CE, de Haas M. Blood group genotyping: from patient to high-throughput donor screening. Vox Sang. 2009;97:198-206.
Thèmes : Méthodes en immuno-hématologie ; maj-2010-04
BTT Wagner FF, Hutinx H, Fontana S, Gowland P, Niederhauser C, Schönitzer D, Storry JR, Olsson ML, van der Schoot CE, Veldhuisen B, de Haas M. Will Genotyping replace serology in future routine blood grouping? [5 differents opinions]. Transfus Med Hemother. 2009;36:226-235.
Thèmes : Méthodes en immuno-hématologie ; maj-2009-10
BTT Dohmen SE, Muit J, Ligthart PC, Verhagen OJ, van der Schoot CE. Anti-e found in a case of hemolytic disease of the fetus and newborn make use of the IGHV3 superspecies genes. Transfusion. 2008;48:194-195.
Thèmes : Allo-immunisation - MHNN ; maj-2008-04
BTT Koelewijn JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion. 2008;48:941-952.
Thèmes : Allo-immunisation - MHNN ; maj-2008-08
BTT Koelewijn JM, de Haas M, Vrijkotte TG, Bonsel GJ, van der Schoot CE. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Transfusion. 2008;48:1721-1729.
Thèmes : Allo-immunisation - MHNN ; maj-2009-01
BTT Tijssen MR, Woelders H, de Vries-van Rossen A, van der Schoot CE, Voermans C, Lagerberg JW. Improved postthaw viability and in vitro functionality of peripheral blood hematopoietic progenitor cells after cryopreservation with a theoretically optimized freezing curve. Transfusion. 2008;48:893-901.
Thèmes : Thérapie cellulaire ; maj-2008-08
BTT Daniels G, van der Schoot CE, Olsson ML. Report of the Second International Workshop on molecular blood group genotyping. Vox Sang. 2007;93:83-88.
Thèmes : Systèmes de groupes sanguins ; Méthodes en immuno-hématologie
BTT Daniels G, Flegel WA, Fletcher A, Garratty G, Levene C, Lomas-Francis C, Moulds JM, Moulds JJ, Olsson ML, Overbeeke MA, Poole J, Reid ME, Rouger P, van der Schoot CE, Scott M, Sistonen P, Smart E, Storry JR, Tani Y, Yu LC, Wendel S, Westhoff CM, Zelinski T. International Society of Blood Transfusion Committee on Terminology for Red Cell Surface Antigens: Cape Town report. Vox Sang. 2007;92:250-253.
Thèmes : Systèmes de groupes sanguins ; maj-2007-04
BTT de Haas M, van der Schoot CE, Beiboer SHW, Feskens M, Cheroutre G, Maaskant-van Wijk PA. Red blood cell and platelet genotyping : from current practice to future high-throughput donor typing. Transfus Med Hemother. 2006;33:260-266.
Thèmes : Antigènes plaquettaires ; Méthodes en immuno-hématologie ; maj-2006-09
BTT Dohmen SE, Verhagen OJ, Muit J, Ligthart PC, van der Schoot CE. The restricted use of IGHV3 superspecies genes in anti-Rh is not limited to hyperimmunized anti-D donors. Transfusion. 2006;46:2162-2168.
Thèmes : Systèmes de groupes sanguins ; Allo-immunisation - MHNN ; maj-2007-04
BTT Grootkerk-Tax MG, Soussan AA, de Haas M, Maaskant-van Wijk PA, van der Schoot CE. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion. 2006;46:2142-2148.
Thèmes : Allo-immunisation - MHNN ; Méthodes en immuno-hématologie ; maj-2007-04
BTT Grootkerk-Tax MG, van Wintershoven JD, Ligthart PC, van Rhenen DJ, van der Schoot CE, Maaskant-van Wijk PA. RHD(T201R, F223V) cluster analysis in five different ethnic groups and serologic characterization of a new Ethiopian variant DARE, the DIII type 6, and the RHD(F223V). Transfusion. 2006;46:606-615.
Thèmes : Systèmes de groupes sanguins ; maj-2006-06
BTT Navarrete C, Contreras M, Dijkstra-Tiekstra MJ, van der Schoot CE, Pietersz RNI, Reesink HW. The immunogenicity of white cell fragments in platelet concentrates. [letter and response]. Vox Sang. 2006;90:205.
Thèmes : Complications immunologiques ; Produits sanguins plaquettaires ; maj-2006-06
BTT Tijssen MR, van der Schoot CE, Voermans C, Zwaginga JJ. Clinical approaches involving thrombopoietin to shorten the period of thrombocytopenia after high-dose chemotherapy. Transfus Med Rev. 2006;20:283-293.
Thèmes : Thérapeutiques de substitution - Facteurs de croissance ; maj-2006-12
BTT van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget-Christiaens LG, de Haas M. Non-invasive antenatal RHD typing. International Conference on Rh protein superfamily. Transfus Clin Biol. 2006;13:53-57.
Thèmes : Systèmes de groupes sanguins ; Méthodes en immuno-hématologie ; maj-2006-09
BTT Beiboer SH, Wieringa-Jelsma T, Maaskant-van Wijk PA, van der Schoot CE, van Zwieten R, Roos D, den Dunnen JT, de Haas M. Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion. 2005;45:667-679.
Thèmes : Méthodes en immuno-hématologie ; maj-2005-10
BTT Daniels G, van der Schoot CE, Olsson ML. Report of the First International Workshop on molecular blood group genotyping. Vox Sang. 2005;88:136-142.
Thèmes : Méthodes en immuno-hématologie ; maj-2005-05
BTT Dijkstra-Tiekstra MJ, van der Schoot CE, Pietersz RN, Reesink HW. White blood cell fragments in platelet concentrates prepared by the platelet-rich plasma or buffy-coat methods. Vox Sang. 2005;88:275-277.
Thèmes : Produits sanguins plaquettaires ; maj-2005-10
BTT Dijkstra-Tiekstra MJ, van der Schoot CE, Pietersz RN, Reesink HW. Storage times of whole blood and of buffy coat determine leucocyte degradation in platelet concentrates. Answer to Dr karger and Dr kretschmer. Vox Sang. 2005;89:171.
Thèmes : Techniques d'obtention des produits sanguins ; Produits sanguins plaquettaires ; maj-2005-12
    page 1/2